Market's view on Novacyt
Published on April 2024
- There are predictions of the share price potentially plummeting to as low as 10p if a court case is lost.
- Some believe that despite selling off some shares, the price could continue to rise and suggest holding the shares as they are performing well.
- Discussions about taking profits as there’s a chance the share price could be driven down again soon.
- A prediction suggests the possibility of the share price hitting £25 within two years.
- There’s a mention of a specific court case where the company, Novacyt S.A., is involved. It is stated that only a specific part of the Department of Health and Social Care’s (DHSC) claim is weak, not the entirety of the case.
- Concerns are expressed that the DHSC’s case against Novacyt S.A. is very weak and might not even pass a pre-trial review, suggesting a possible significant revaluation of the company’s stock in the future.
- Various expressions of skepticism about the reach of the share price to £25, referencing hyperinflation and economic instability as unlikely factors that would need to occur for such a price target to be met.